These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23265908)

  • 1. Predicting acute cardiac rejection from donor heart and pre-transplant recipient blood gene expression.
    Hollander Z; Chen V; Sidhu K; Lin D; Ng RT; Balshaw R; Cohen-Freue GV; Ignaszewski A; Imai C; Kaan A; Tebbutt SJ; Wilson-McManus JE; McMaster RW; Keown PA; McManus BM;
    J Heart Lung Transplant; 2013 Feb; 32(2):259-65. PubMed ID: 23265908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood genomic biomarkers of acute cardiac allograft rejection.
    Lin D; Hollander Z; Ng RT; Imai C; Ignaszewski A; Balshaw R; Freue GC; Wilson-McManus JE; Qasimi P; Meredith A; Mui A; Triche T; McMaster R; Keown PA; McManus BM; ;
    J Heart Lung Transplant; 2009 Sep; 28(9):927-35. PubMed ID: 19716046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Jarcho J; Naftel DC; Shroyer TW; Kirklin JK; Bourge RC; Barr ML; Pitts DG; Starling RC
    J Heart Lung Transplant; 1994; 13(4):583-95; discussion 595-6. PubMed ID: 7947874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive role of pretransplant serum CXCL10 for cardiac acute rejection.
    Crescioli C; Buonamano A; Scolletta S; Sottili M; Francalanci M; Giomarelli P; Biagioli B; Lisi G; Pradella F; Serio M; Romagnani P; Maccherini M
    Transplantation; 2009 Jan; 87(2):249-55. PubMed ID: 19155980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of gender on heart transplantation outcomes: a single center experience.
    De Santo LS; Marra C; De Feo M; Amarelli C; Romano G; Cotrufo M
    Ital Heart J; 2002 Jul; 3(7):419-23. PubMed ID: 12189971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
    J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome.
    Ypsilantis E; Key T; Bradley JA; Morgan CH; Tsui S; Parameshwar J; Taylor CJ
    J Heart Lung Transplant; 2009 Nov; 28(11):1206-10. PubMed ID: 19782609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient.
    Damman J; Seelen MA; Moers C; Daha MR; Rahmel A; Leuvenink HG; Paul A; Pirenne J; Ploeg RJ
    Transplantation; 2011 Jul; 92(2):163-9. PubMed ID: 21677599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
    Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
    Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-recipient sex mismatch portends poor 10-year outcomes in a single-center experience.
    Kittleson MM; Shemin R; Patel JK; Ardehali A; Kawano M; Davis S; Moriguchi JD; Kobashigawa JA
    J Heart Lung Transplant; 2011 Sep; 30(9):1018-22. PubMed ID: 21550824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.